Breathing Study for Brachycephalic Dogs

This clinical research program is investigating SnoreTox, a treatment being evaluated in selected brachycephalic (flat-faced) dogs with airway disease.

The treatment involves administering tetanus toxoid to specific airway muscles under sedation or anaesthesia.

Current Study Status

Recruitment for the first phase of the study has been completed.

Further studies are planned. Additional recruitment may occur in the future.

Treatment Context

SnoreTox is being studied as:

• An adjunct to surgery

• An option for dogs where surgery may not be advisable

• Part of an individual treatment plan

It is not considered a replacement for surgery in dogs with significant structural airway obstruction.

Eligibility for Future Studies

Dogs may be considered for future studies if they:

• Are brachycephalic breeds with moderate to severe airway disease

• Are suitable for sedation or anaesthesia

• May have had previous airway surgery

• Meet inclusion criteria after assessment

Final eligibility is determined following clinical review.

What Participation May Involve

Depending on the study phase, participation may include:

• Clinical examination and airway assessment

• Imaging such as CT where required

• Treatment administration under sedation or anaesthesia

• Follow-up visits over several months

Details may vary between studies.

Referrals and Enquiries

Veterinarians with potential candidates, or owners seeking further information, are welcome to contact:

Dr Arthur House
arthur@drarthurhouse.com.au